Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Parents advised to use out-of-date EpiPens, but call 999, as shortage continues

NHS England has written to parents and carers of children that use EpiPen Jr advising on them on what to do in the event of a severe allergic or anaphylactic reaction as the shortage of EpiPens continues.

The advice letter, sent on 15 October 2018, instructs parents and carers to give children their EpiPen even if the pen is out of date and they have not been able to get a new one. The letter also states that you should call 999 if you need to use a pen that is out of date.

“An out-of-date pen might give your child a lower dose of adrenaline but it is not dangerous and is better than no immediate treatment,” the advice explains.

EpiPen Jr contains 150μg of adrenaline and the letter says that GPs should prescribe a standard 300μg pen for children who weigh more than 25kg. It reassures parents that although the pen might say it is for people who weigh more than 30kg, it can be used safely for children who weigh above 25kg.

The letter, written by Aidan Fowler, national director of patient safety at NHS England, says that new stock of EpiPens is expected “in the next week”.

Pharmacists have faced EpiPen shortages since the product’s supplier, Mylan, highlighted a shortage of supply in May 2018.

In a further update in September 2018, Mylan confirmed that the lack of supply also affected EpiPen Jr. As a result, pharmacists were allocated products on a prescription-only basis, but could only place orders for two per prescription.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205600

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.